EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pharmacogenetic considerations in therapy with novel antiplatelet and anticoagulant agents

Anthony Yazbeck, Reem Akika, Zainab Awada, Nathalie K Zgheib

Pharmacogenetics and Genomics · 2024

DOI: 10.1097/fpc.0000000000000520 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacogenetics and Genomics, 2024. Verfasst von Anthony Yazbeck und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, American University of Beirut. Hauptthemen laut MEDLINE: Anticoagulants, Warfarin. Die Arbeit nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiplatelets and anticoagulants are extensively used in cardiovascular medicine for the prevention and treatment of thrombosis in the venous and arterial circulations. Wide inter-individual variability has been observed in response to antiplatelets and anticoagulants, which triggered researchers to investigate the genetic basis of this variability. Data from extensive pharmacogenetic studies pointed to strong evidence of association between polymorphisms in candidate genes and the pharmacokinetics and pharmacodynamic action and clinical response of the antiplatelets clopidogrel and the anticoagulant warfarin. In this review, we conducted an extensive search on Medline for the time period of 2009–2023. We also searched the PharmGKB website for levels of evidence of variant-drug combinations and for drug labels and clinical guidelines. We focus on the pharmacogenetics of novel antiplatelets and anticoagulants while excluding acetylsalicylic acid, warfarin and heparins, and discuss the current knowledge with emphasis on the level of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsWarfarinHumansPharmacogeneticsClopidogrelPolymorphism, GeneticPlatelet Aggregation Inhibitors

Substanzen

AnticoagulantsWarfarinClopidogrelPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Faculty of Medicine, American University of Beirut.
  • Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Zitieren

APA

Yazbeck, A., Akika, R., Awada, Z., & Zgheib, N. K. (2024). Pharmacogenetic considerations in therapy with novel antiplatelet and anticoagulant agents. Pharmacogenetics and Genomics. https://doi.org/10.1097/fpc.0000000000000520

Vancouver

Yazbeck A, Akika R, Awada Z, Zgheib NK. Pharmacogenetic considerations in therapy with novel antiplatelet and anticoagulant agents. Pharmacogenetics and Genomics. 2024. doi:10.1097/fpc.0000000000000520

BibTeX
@article{Yazbeck2024,
  author = {Yazbeck, Anthony and Akika, Reem and Awada, Zainab and Zgheib, Nathalie K},
  title = {Pharmacogenetic considerations in therapy with novel antiplatelet and anticoagulant agents},
  journal = {Pharmacogenetics and Genomics},
  year = {2024},
  doi = {10.1097/fpc.0000000000000520}
}
Kostenlos starten →